Broadly covered and affordable for most patients*

Because LEQVIO® is administered by an HCP, it is covered primarily under the medical benefit, not the pharmacy benefit

For traditional Medicare patients, LEQVIO may be:
Check box icon Covered, Affordable

No prior authorization required


80%

Have supplemental plans and
may pay as little as $0

Some supplemental plans may require
precertification or prior authorization.


Part B medical benefit


Not subject to the Part D
pharmacy benefit donut hole

Medicare card
For commercial & Medicare patients, LEQVIO may be:
Check box icon Covered
9 out of 10

Have confirmed coverage on
the medical benefit for LEQVIO


9 out of 10

Patients' medical insurance plans
do not require a step through another injectable


Higher approval rates when
appropriately submitted under
the medical benefit


Check box icon Affordable
65%

May pay as little as $0


Patients pay

35%

Out-of-pocket annually vs other branded nonstatin treatments, including PCSK9 mAbs

For Medicaid patients, LEQVIO may be:
Check box icon Affordable

Patients pay less than

$10

HCP, health care professional; PCSK9 mAb, proprotein convertase subtilisin/kexin type 9 monoclonal antibody.

*Coverage information is subject to change by the relevant plan and is based on data up to July 2023. The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims.

The comparison pertains only to differences in cost and should not be considered a comparison of efficacy or safety.

Reference: Data on file. LEQVIO Coverage and Affordability. Novartis Pharmaceuticals Corp; 2023.

Quickly check medical benefit coverage
for LEQVIO in your area

Enter your ZIP Code to get specific coverage criteria.

Please enter a valid 5-digit ZIP Code.

Select Insurance Type

COMMERCIAL coverage for LEQVIO in the area

Select plan for LEQVIO coverage details

The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. Nothing herein may be construed as an endorsement, approval, recommendation, representation or warranty of any kind by any plan or insurer referenced herein. The comparison pertains only to differences in cost and should not be considered a comparison of efficacy or safety.

Plan Maximum tolerated statin Ezetimibe PCSK9 mAb Site of care restriction Documentation required Specialist consult
Swipe to view more
Plan Maximum tolerated statin Ezetimibe PCSK9 mAb Site of care restriction Documentation required Specialist consult

We're sorry, no coverage details are available.

Please call 833-LEQVIO2 (833-537-8462) with questions, or complete the Start Form to receive a personalized benefits
investigation for your patient's plan.

MEDICARE coverage for LEQVIO in the area

Select plan for LEQVIO coverage details

The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. Nothing herein may be construed as an endorsement, approval, recommendation, representation or warranty of any kind by any plan or insurer referenced herein. The comparison pertains only to differences in cost and should not be considered a comparison of efficacy or safety.

Plan Maximum tolerated statin Ezetimibe PCSK9 mAb Site of care restriction Documentation required Specialist consult
Swipe to view more
Plan Maximum tolerated statin Ezetimibe PCSK9 mAb Site of care restriction Documentation required Specialist consult

We're sorry, no coverage details are available.

Please call 833-LEQVIO2 (833-537-8462) with questions, or complete the Start Form to receive a personalized benefits
investigation for your patient's plan.

MEDICAID coverage for LEQVIO in the area

Select plan for LEQVIO coverage details

The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. Nothing herein may be construed as an endorsement, approval, recommendation, representation or warranty of any kind by any plan or insurer referenced herein. The comparison pertains only to differences in cost and should not be considered a comparison of efficacy or safety.

Plan Maximum tolerated statin Ezetimibe PCSK9 mAb Site of care restriction Documentation required Specialist consult
Swipe to view more
Plan Maximum tolerated statin Ezetimibe PCSK9 mAb Site of care restriction Documentation required Specialist consult

We're sorry, no coverage details are available.

Please call 833-LEQVIO2 (833-537-8462) with questions, or complete the Start Form to receive a personalized benefits
investigation for your patient's plan.

IMPORTANT SAFETY INFORMATION
AND INDICATION

Expand Collapse

IMPORTANT SAFETY INFORMATION

LEQVIO is contraindicated in patients with a prior serious hypersensitivity reaction to inclisiran or any of the excipients in LEQVIO. Serious hypersensitivity reactions have included angioedema. Adverse reactions in clinical trials (≥3% of patients treated with LEQVIO and more frequently than placebo) were injection site reaction, arthralgia, and bronchitis.

Please click here for LEQVIO full Prescribing Information.

INDICATION

LEQVIO (inclisiran) injection is indicated as an adjunct to diet and statin therapy for the treatment of adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce low-density lipoprotein cholesterol (LDL-C).

Please click here for LEQVIO full Prescribing Information.